We do not publish a verdict for Accendra Health Inc (ACH) and Mckesson Corp (MCK) is undervalued.
We publish an intrinsic value for MCK but not for ACH, so the two cannot be ranked on price.
Values as of the 22 Sept 2026 close.
We do not publish a value for this company: its projected cash flows are negative in every year, including the terminal one.
Leak Score 0/100 on 1 of 12 signals
Discounting its cash flows at 7.5% (average of 3 methods) values the shares at $1250.61; the price of $891.23 is 29% below that value, and 82% of that value comes from beyond year five.
Leak Score 78/100 on 8 of 12 signals
| Metric | ACH | MCK |
|---|---|---|
| Verdict | Not valued | Undervalued |
| Price | $0.85 | $891.23 |
| Intrinsic value | — | $1250.61 |
| Margin of safety | — | +29% |
| Leak Score | 0/100 (1/12) | 78/100 (8/12) |
| Market cap | $65M | $103.9B |
| Revenue growth, 5 years | -20.1% | 11.1% |
| Operating margin | 1.4% | 1.6% |
| Net margin | -11.4% | 1.1% |
| Return on equity | -198.3% | — |
| P/E | — | 23.9x |
| Forward P/E | 4.7x | 17.6x |
| Dividend yield | — | 0.4% |